Those with Celiac disease may not have to wait much longer for relief. Veuer’s Tony Spitz has the details.
You may be sick of hearing about gluten allergies, but celiac disease is a very real thing that Beyond Gluten estimates affects 1 in every 133 Americans.
That means celiac literally affects millions of people in the U.S.
And if you think hearing people talk about their gluten allergy is annoying, just think if you could never have this… or this… or this!
And currently that’s the only real way we treat celiac… avoidance.
But since no one wants to give up pizza for the rest of their life,
researchers from Technical University of Vienna and pharmaceutical company Sciotech are looking at a completely different way to treat the disease.
Like all allergies, celiac symptoms happens when the body recognizes antigens within the protein gluten.
But the immune response happens in your gut, not your nose.
So researchers have now developed two antibodies that quote “like a lock and key,” bind themselves to gluten antigens and stop the immune response.
And researchers think they may have a viable drug to alleviate the painful symptoms of celiac by as early as 2021.
No, they won’t beat the pizza delivery guy to your door in 30-minutes or less, but let’s just say it’ll be worth the wait.